EF Hutton Assumes Trxade Health at Buy, Announces Price Target of $1.25
EF Hutton Maintains Buy on Trxade Health, Lowers Price Target to $1.25
Maxim Adjusts Price Target on Trxade Health to $1.75 From $2.50, Maintains Buy Rating
Maxim Group Maintains Buy on Trxade Health, Lowers Price Target to $1.75
No Data